Skip to main content
. 2024 Nov 6;17:4875–4885. doi: 10.2147/IDR.S480520

Table 4.

Initial Response to Treatment and Related Factors

Responder n:63, % Non-Responder n:36, % p t test
Male sex 37 (58.7) 27 (75.0) 0.103
PSIa class t (97)=−1.94, p=0.045
 I 2 (5.0) 0 -
 II 12 (32.4) 4 (11.1) 0.302
 III 11 (29.7) 4 (11.1) 0.396
 IV 23 (62.1) 15 (41.6) 0.611
 V 15 (40.5) 13 (36.1) 0.191
CURB-65b score t (97)=−1.15, p=0.256
 0 13 (20.6) 6 (16.6) 0.629
 1 16 (25.3) 8 (22.2) 0.722
 2 23 (36.5) 12 (33.3) 0.750
 3 8 (12.6) 6 (16.6) 0.585
 4 3 (4.0) 4 (11.1) 0.235
 5 - -
CCIc t (97)=−1.30, p=0.232
 ≥ 6 points 17d (28.3) 15 (41.6) 0.179
 Age in years ≥ 65 29 (46.0) 20 (55.5) 0.361 t (97)=−0.16, p=0.871
 Respiratory Rate 0.041 t (96)=−2.04, p=0.043
Empirical Antibiotherapy
 B-lactam 27 (42.8) 11 (30.5) 0.256
 B-lactam+Macrolide 15 (23.8) 11 (30.5) 0.415
 B-lactam+FQe 15 (23.8) 10 (27.7) 0.608
 FQ 4 (6.0) 2 (5.0) 0.896
Time to initial antibiotic administration (first hour) 18 (27.6) 15 (41.6) 0.185
CRPf (mg/L) 0.991 t (97)=0.12, p=0.991
Procalcitonin (ng/mL) 0.115 t (81)=−0.99, p=0.921
Leucocyte (cells/mm3) 0.534 t (97)=−0.59, p=0.555
LDHg 0.008 t (89)=−2.82, p=0.006

Notes: aPSI; Pneumonia severity index, bCURB-65; Confusion, urea, respiratory rate, blood pressure, cCCI; Charlson’s Comorbidity Index, d3 missing data, eFQ; Fluoroquinolone, fCRP; C-reactive peptide, gLDH; Lactate dehydrogenase.